The global proteomics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 14.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions. Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.
The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques. These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market.
Breakup by Analysis Type:
- Structural Proteomics
- Functional Proteomics
- Protein Expression Proteomics
Breakup by Component Type:
- Core Proteomics Services
- Bioinformatics Software and Related Services
Breakup by Technology:
- Spectroscopy
- Chromatography
- Electrophoresis
- Protein Microarrays
- X-Ray Crystallography
- Surface Plasmon Resonance
- Others
Breakup by Application:
- Protein Expression Profiling
- Proteome Mining
- Post-translational Modifications
Breakup by End-User:
- Clinical Diagnostic Laboratories
- Research Organizations (Drug Discovery)
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.
Report Coverages:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Analysis Type, Component Type, Technology, Application, End-User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc. and Waters Corporation |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global proteomics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global proteomics market?
- What is the breakup of the market based on the analysis type?
- What is the breakup of the market based on the component type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global proteomics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Proteomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Analysis Type
6.1 Structural Proteomics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Functional Proteomics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Protein Expression Proteomics
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Component Type
7.1 Core Proteomics Services
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bioinformatics Software and Related Services
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Technology
8.1 Spectroscopy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Chromatography
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Electrophoresis
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Protein Microarrays
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 X-Ray Crystallography
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Surface Plasmon Resonance
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by Application
9.1 Protein Expression Profiling
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Proteome Mining
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Post-translational Modifications
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by End-User
10.1 Clinical Diagnostic Laboratories
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Research Organizations (Drug Discovery)
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bio-RAD Laboratories Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bruker Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Creative Proteomics
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Danaher Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 GE Healthcare Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Horiba Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Luminex Corporation
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Merck Group
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Perkinelmer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Promega Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Waters Corporation
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Proteomics Market: Major Drivers and Challenges
Figure 2: Global: Proteomics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Proteomics Market: Breakup by Analysis Type (in %), 2020
Figure 4: Global: Proteomics Market: Breakup by Component Type (in %), 2020
Figure 5: Global: Proteomics Market: Breakup by Technology (in %), 2020
Figure 6: Global: Proteomics Market: Breakup by Application (in %), 2020
Figure 7: Global: Proteomics Market: Breakup by End-User (in %), 2020
Figure 8: Global: Proteomics Market: Breakup by Region (in %), 2020
Figure 9: Global: Proteomics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 10: Global: Proteomics (Structural Proteomics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Proteomics (Structural Proteomics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Proteomics (Functional Proteomics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Proteomics (Functional Proteomics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Proteomics (Protein Expression Proteomics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Proteomics (Protein Expression Proteomics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Proteomics (Core Proteomics Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Proteomics (Core Proteomics Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Proteomics (Bioinformatics Software and Related Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Proteomics (Bioinformatics Software and Related Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Proteomics (Spectroscopy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Proteomics (Spectroscopy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Proteomics (Chromatography) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Proteomics (Chromatography) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Proteomics (Electrophoresis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Proteomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Proteomics (Protein Microarrays) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Proteomics (Protein Microarrays) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Proteomics (X-Ray Crystallography) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Proteomics (X-Ray Crystallography) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Proteomics (Surface Plasmon Resonance) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Proteomics (Surface Plasmon Resonance) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Proteomics (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Proteomics (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Proteomics (Protein Expression Profiling) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Proteomics (Protein Expression Profiling) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Proteomics (Proteome Mining) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Proteomics (Proteome Mining) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: Proteomics (Post-translational Modifications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: Proteomics (Post-translational Modifications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Global: Proteomics (Clinical Diagnostic Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Global: Proteomics (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Global: Proteomics (Research Organizations- Drug Discovery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Global: Proteomics (Research Organizations- Drug Discovery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Global: Proteomics (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Global: Proteomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: North America: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: North America: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: United States: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: United States: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Canada: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Canada: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Asia Pacific: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Asia Pacific: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: China: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: China: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Japan: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Japan: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: India: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: India: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: South Korea: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: South Korea: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Australia: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Australia: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Indonesia: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Indonesia: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Europe: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Europe: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Germany: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Germany: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: France: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: France: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: United Kingdom: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: United Kingdom: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Italy: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Italy: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Spain: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Spain: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Russia: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Russia: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Latin America: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Latin America: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Brazil: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 87: Brazil: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Mexico: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 89: Mexico: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: Others: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 91: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 92: Middle East and Africa: Proteomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 93: Middle East and Africa: Proteomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 94: Global: Proteomics Industry: SWOT Analysis
Figure 95: Global: Proteomics Industry: Value Chain Analysis
Figure 96: Global: Proteomics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Proteomics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Proteomics Market Forecast: Breakup by Analysis Type (in Million US$), 2021-2026
Table 3: Global: Proteomics Market Forecast: Breakup by Component Type (in Million US$), 2021-2026
Table 4: Global: Proteomics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 5: Global: Proteomics Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 6: Global: Proteomics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 7: Global: Proteomics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 8: Global: Proteomics Market Structure
Table 9: Global: Proteomics Market: Key Players